Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which reading glasses give the best view? new study puts three lens designs to the test

NCT ID NCT07617090

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares three types of progressive lenses to see which provides the widest clear vision at distances from 4 meters down to 25 centimeters. About 26 presbyopic participants will test each lens in a random, double-blind order. The goal is to help eye doctors choose the best lens for people who need sharp vision at both arm's length and close up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
progressive addition lenses (PALs)
What this could lead to
If successful, this study could help eye doctors recommend the best lens design for people who need clear vision at arm's length and close up.
What could go wrong
This is a small, early-stage study with only 26 participants, so results may not apply to everyone. The main risk is temporary eye strain from testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Sep 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

52 to 67 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Spherical ametropia for distance vision ≤ ±4.00 D and astigmatic ametropia ≤ 1.00 D. * Decimal VA ≥ 0.8, either uncorrected (UCVA) or corrected (BCVA) with monofocal contact lenses. * Patients with a nasopupillary distance (NPD) of 31 mm, with a tolerance of ±2 mm in each eye Exclusion Criteria: * Astigmatism greater than ±1.00 D. * Patients wearing progressive contact lenses. * Patients who have undergone cataract surgery or have monofocal or multifocal intraocular lenses. * Anisometropia greater than 2.50 D. * Decimal distance visual acuity \< 0.8 (UCVA or BCVA) with monofocal contact lenses. * Patients without normal ocular motility or with partial dysfunction of one or more ex-traocular muscles, or with restricted visual fields or scotomas. * Visual suppression in one eye between 4 m and 25 cm. * Strabismus or nystagmus.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Presbyopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pharmacy school, University of Seville

    Seville, Sevilla, 41012, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.